Salud financiera de hoja de balance de Oxford Biomedica
Salud financiera controles de criterios 4/6
Oxford Biomedica has a total shareholder equity of £71.2M and total debt of £39.7M, which brings its debt-to-equity ratio to 55.8%. Its total assets and total liabilities are £245.0M and £173.8M respectively.
Información clave
55.8%
Ratio deuda-patrimonio
UK£39.74m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | UK£81.41m |
| Patrimonio | UK£71.22m |
| Total pasivo | UK£173.75m |
| Activos totales | UK£244.97m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: OXBD.F's short term assets (£138.9M) exceed its short term liabilities (£59.1M).
Pasivo a largo plazo: OXBD.F's short term assets (£138.9M) exceed its long term liabilities (£114.6M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: OXBD.F has more cash than its total debt.
Reducción de la deuda: OXBD.F's debt to equity ratio has increased from 0% to 55.8% over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: OXBD.F has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: Insufficient data to determine if OXBD.F has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.